05.06.2014
- Adaptimmune, a biotechnology company developing TCR engineered T-cells to treat cancer, has begun a strategic collaboration and licensing agreement with GlaxoSmithKline (GSK) for...
25.04.2014
- AstraZeneca has unveiled plans to sell or partner infection and neuroscience units with combined 2013 sales of $3.5 billion and a basis in antibiotics and antipsychotics as well as...
23.04.2014
- In reports that emerged at Easter, U.S. pharmaceutical giant Pfizer is said to have held informal talks with AstraZeneca about buying the London-based maker of asthma and heart...
19.02.2014
- Swiss pharmaceuticals giant Novartis has announced plans to acquire U.S. biotech firm CoStim. The privately owned cancer therapy specialist based at Cambridge, Massachusetts...
12.02.2014
- EU rules dating from 2007, allowing pharmaceutical companies to opt out of pediatric trials with new cancer medicines if the disease they are intended to treat rarely affects...
23.12.2013
- Merck Serono, the biopharmaceuticals division of Germany's Merck KGaA, has signed a global license agreement with the Spanish National Research Center (CNIO) in Madrid on cancer...
05.11.2013
- With three quarters of 2013 behind it, Germany's Bayer group sees itself as still on track to fulfil the "ambitious forecast" for 2013 voiced by CEO Marijn Dekkers earlier this...
28.10.2013
- Merck Serono, the biopharmaceuticals arm of Germany's Merck KGaA, has agreed an oncology research pact with Polish biotech company Selvita. The aim of the collaboration is to...
